From the news

Recent transaction and litigation

Publications

February / 2014

Representation of PrimeSense in its acquisition by a multinational corporation

Meitar Represented PrimeSence, 3D sensing technology developer company, in its acquisition by a multinational corporation.

January / 2014

Representation of Covidien in its acquisition of Given Imaging for approximately $1 billion

Meitar represented NYSE-listed Covidien, a US medical device manufacture, in its acquisition of Given Imaging, a medical technology company that develops and manufactures the swallowable imaging capsules for endoscopy, for approximately $1 billion.

January / 2014

Representation of Conduit

Meitar represented Conduit in its spin-off of ClientConnect, Conduit’s toolbar division, and the subsequent purchase of ClientConnect by Perion Network Ltd., a NASDAQ company, in an all stock transaction. Conduit’s shareholders and option holders received 81% of Perion shares in the transaction, which closed in January 2014.

November / 2012

Representation of Bitan Wines food chain

Meitar represented Bitan Wines food chain in its acquisition of Zim Marketing Ltd., the owner of the “Half-Off” food chain, to become the third largest retail chain in Israel.

November / 2012

Action against the Netherlands Company ASML Dismissed

Meitar successfully defended ASML, a Netherlands company, in a NIS 20 million subrogation action brought by Migdal Insurance Company. The action was dismissed in light of a foreign jurisdiction provision in the agreement between ASML and the insured (Tower Semiconductor).

November / 2012

Representation of the shareholders of DesignArt in its acquisition by Qualcomm

Meitar represented Carmel Ventures and Magma Ventures, shareholders of Israeli chip company DesignArt, in its acquisition by Qualcomm – the world leader in 3G and next-generation mobile technologies.

November / 2012

Motion to Certify a Major Class Action Dismissed

Meitar successfully defended an accounting firm in defending against a motion to certify a multimillion dollar class action claim, leading to the denial of the motion. The plaintiffs have filed an appeal to the Supreme Court, which is pending. The claim involves novel issues of securities law and professional negligence as applied to class action claims.